Mini Review
Accepted on 17 May 2024
siRNA Therapy in Osteoarthritis: Targeting Cellular Pathways for Advanced Treatment Approaches
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2024.1382689
Type at least 3 characters
1,058 articles
Articles
Original Research
Published on 17 May 2024
IFNγ at the early stage induced after cryo-thermal therapy maintains CD4+ Th1-prone differentiation, leading to long-term antitumor immunity
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2024.1345046
- 162 views
Review
Published on 17 May 2024
Extracellular vescicles in psoriasis: from pathogenesis to possible roles in therapy
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2024.1360618
- 204 views
Original Research
Accepted on 16 May 2024
Extracellular CIRP promotes Kupffer cell inflammatory polarization in sepsis
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2024.1411930
Systematic Review
Accepted on 15 May 2024
Global Research Trends and Hotspots for Leukocyte cellderived chemotaxin-2 from the Past to 2023: A Combined Bibliometric Review
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2024.1413466
Original Research
Published on 15 May 2024
IL-2Rα KO mice exhibit maternal microchimerism and reveal nuclear localization of IL-2Rα in lymphoid and non-lymphoid cells
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2024.1369818
- 226 views
Original Research
Published on 15 May 2024
MCP-3 as a prognostic biomarker for severe fever with thrombocytopenia syndrome: a longitudinal cytokine profile study
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2024.1379114
- 156 views
Review
Accepted on 14 May 2024
Methods to accelerate fracture healing - a narrative review from a clinical perspective
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2024.1384783
Review
Published on 13 May 2024
Regulation of Treg cells by cytokine signaling and co-stimulatory molecules
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2024.1387975
- 154 views
Original Research
Published on 10 May 2024
The atypical chemokine receptor 2 reduces T cell expansion and tertiary lymphoid tissue but does not limit autoimmune organ injury in lupus-prone B6lpr mice
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2024.1377913
- 132 views
Original Research
Accepted on 09 May 2024
Predicting Chemotherapy Toxicity in Multiple Myeloma: The Prognostic Value of Pre-Treatment Serum Cytokine Levels of Interleukin-6 (IL-6), Interleukin-8 (IL-8), Monocyte Chemoattractant Protein-1 (MCP-1), and Vascular Endothelial Growth Factor (VEGF)
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2024.1377546
Original Research
Accepted on 07 May 2024
Whole blood culture-derived cytokine combinations for the diagnosis of tuberculosis
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2024.1397941
Original Research
Accepted on 06 May 2024
The predictive value of TNF family for pulmonary tuberculosis: A pooled causal effect analysis of multiple datasets
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2024.1398403
Original Research
Accepted on 01 May 2024
LTβR-RelB signaling in intestinal epithelial cells protects from chemotherapy-induced mucosal damage
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2024.1388496
Original Research
Accepted on 29 Apr 2024
Distinct TB-Antigen Stimulated Cytokine Profiles as Predictive Biomarkers for Unfavorable Treatment Outcomes in Pulmonary Tuberculosis
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2024.1392256
Original Research
Published on 29 Apr 2024
Exploring causal correlations between inflammatory cytokines and Ménière’s disease: a Mendelian randomization
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2024.1373723
- 638 views